Company
United StatesPublic company, NASDAQ: AXGNAxogen Corporation (NASDAQ: AXGN), Tampa, FL – FDA Inspections
Inspection records and compliance data for Axogen Corporation in Tampa, Florida. 2 FDA inspections on record, last inspected March 06, 2025. Publicly traded as NASDAQ: AXGN.
Company Profile
This profile covers Axogen Corporation based in Tampa, Florida, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected February 29, 2024. Last inspected March 6, 2025.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 6, 2025 | NAI | Biologics · Bioresearch Monitoring | 1264741 |
| February 29, 2024 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 1232568 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Axogen Corporation
Stock ticker
AXGN
Exchange
NASDAQ
Share price
$48.92
Market cap
$2.9B
Price as of
November 6, 2026
FEI Number
3017860045
Address
111 W Oak Ave, Tampa, Florida 33602, United States
Country
United States
ID: 68eb0cbb-a9e9-482d-9953-4ddb866a8dc8